Efficacy and Safety Phase II Study of SR-T100 to Treat Actinic Keratosis
Status:
Completed
Trial end date:
2018-10-01
Target enrollment:
Participant gender:
Summary
This Phase II study is to evaluate the efficacy of SR-T100 gel with 2.3% of SM in Solanum
undatum plant extract in patient with Actinic Keratosis (AK).